A United States drug manufacturer has taken an important step to open the way to improved access to the treatment of multidrug-resistant tuberculosis (MDR-TB) across Africa, AllAfrica reports. Johnson & Johnson announced on September 29 that it will no longer enforce patents for the drug bedaquiline, which it sells as SIRTURO, in 134 low- and middle-income countries. Its announcement frees companies making generic versions of the drug to manufacture them at lower prices without fear of being sued for doing so. The announcement has been hailed by the humanitarian medical care NGO, Médecins Sans Frontières, as a "huge success" resulting from campaigns by TB activists, civil society and countries which "prioritis[e] public health over corporations' interests."
A United States drug manufacturer has taken an important step to open the way to improved access to the treatment of multidrug-resistant tuberculosis across Africa,that it will no longer enforce patents for the drug bedaquiline, which it sells as SIRTURO, in 134 low- and middle-income countries. Its announcement frees companies making generic versions of the drug to manufacture them at lower prices without fear of being sued for doing so.
An American drug manufacturer has taken an important step to open the way to improved access to the treatment of multidrug-resistant tuberculosis across Africa. Applause rang out in one of the main conference rooms at UN headquarters on Friday as world leaders, civil society representatives and other stakeholders approved a declaration to… Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization, addresses the second high-level United Nations meeting on the fight against tuberculosis, September 22, 2023.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Africa: Breakthrough Promises Improved Access to TB Treatment Across AfricaAn American drug manufacturer has taken an important step to open the way to improved access to the treatment of multidrug-resistant tuberculosis (MDR-TB) across Africa.
Read more »
Africa’s Medical Brain Drain: The Africa Report.comA report released by the WHO in March identified 55 countries – including 40 African countries – with significant medical staff shortages. One week later, the British government’s National Health Service (NHS) issued a directive, saying it would not recruit doctors, nurses, or other medical staff from those 40 countries. In this six-part series, we look at how and why medical staff around the continent are leaving in droves.
Read more »
South Africa: Business Leaders Join Principals in Plan to Transform South Africa's Ailing Education SystemAnalysis - The Execs Back to School programme goes beyond physical improvements and providing resources to schools, it seeks to instil a mindset of continuous improvement and growth within the education system.
Read more »
Africa: Johnson & Johnson Confirms Intent Not to Enforce Patents for SIRTURO® (bedaquiline) for the Treatment of Multidrug-Resistant Tuberculosis in 134 Low- and Middle-Income CountriesPress Release - Company continues to be focused on addressing perceived barriers to access and refocusing global efforts on the most-pressing barrier to access: underdiagnosis of the disease.
Read more »
Amputated arm, failed promises - medical negligence costs two-year old dearlyLwandle’s arm was amputated just four weeks after her birth after birth and a drip was allegedly wrongfully administered on her right-hand wrist, which led to an infection.
Read more »